Literature DB >> 1525051

Direct stimulation by estrogen of growth factor signal transduction pathways in human breast cancer cells.

B van der Burg1, R P de Groot, L Isbrücker, W Kruijer, S W de Laat.   

Abstract

Estrogen is thought to stimulate the proliferation of human breast tumors indirectly, through induced production of autocrine polypeptide growth factors. Constitutive production of such growth factors would lead to the loss of 17 beta-estradiol (E2)-dependence that is associated with progression of the disease. Our data, however, do not support this hypothesis and suggest that hormone-dependent breast tumor cell lines like MCF7 do not react to the growth factors which they produce. Moreover, we provide evidence that E2 directly stimulates proliferation by inducing, like many growth factors, the c-fos proto-oncogene. E2 by itself, however, is poorly mitogenic. This may be caused by the lack of induction of genes from the jun family, whose gene products are necessary for dimerization with the c-fos encoded protein, leading to an important step in growth factor signalling pathways; stimulation of TPA responsive element (TRE)-dependent transcriptional activity. In combination with insulin-like growth factors, efficient inducers of c-jun in these cells, E2 synergistically stimulates proliferation and TRE-activity. Constitutive TRE-activation may lead to loss of E2-dependence.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1525051     DOI: 10.1016/0960-0760(92)90194-n

Source DB:  PubMed          Journal:  J Steroid Biochem Mol Biol        ISSN: 0960-0760            Impact factor:   4.292


  3 in total

Review 1.  Mammary tumors induced by polyomavirus.

Authors:  M M Fluck; S Z Haslam
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

2.  Efficacy of Denosumab Therapy Following Treatment with Bisphosphonates in Women with Osteoporosis: A Cohort Study.

Authors:  Chiara Marocco; Giovanna Zimatore; Edoardo Mocini; Rachele Fornari; Giovanni Iolascon; Maria Chiara Gallotta; Viviana Maria Bimonte; Carlo Baldari; Andrea Lenzi; Silvia Migliaccio
Journal:  Int J Environ Res Public Health       Date:  2021-02-10       Impact factor: 3.390

3.  Significant improvement of bone mineral density by denosumab treatment in Japanese osteoporotic patients following breast cancer treatment.

Authors:  Yukio Nakamura; Mikio Kamimura; Akio Morikawa; Akira Taguchi; Takako Suzuki; Hiroyuki Kato
Journal:  Ther Clin Risk Manag       Date:  2018-03-14       Impact factor: 2.423

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.